FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

28,490 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 6200 - 6400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1028Procedures for Sexual Activityactive2024-02ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1030Procedures for Sexual Activityactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1031Diagnosis for Sexual Activityactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1032Diagnosis for Sexual Activityactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.11.1033Procedures for Sexual Activityactive2021-02ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1007Lab Tests During Pregnancyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1008Diagnostic Studies During Pregnancyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1011Pregnancy Testactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1012Complications of Pregnancy, Childbirth and the Puerperiumactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1016Congenital or Acquired Absence of Cervixactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1017Procedures Used to Indicate Sexual Activityactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.111.12.1018Diagnoses Used to Indicate Sexual Activityactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.112.11.1024Absence of Cervixactive2021-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.112.11.1025Absence of Cervixactive2021-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.112.11.1026Absence of Cervixactive2023-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1073Osteoporosis Without Current Fractureactive2017-12ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1074Osteoporosis Without Current Fractureactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1200Osteoporosis With Current Fractureactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1201Osteoporosis With Current Fractureactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1202DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spineactive2021-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1308Frailty Diagnosisactive2024-11ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1309Frailty Diagnosisactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1310Frailty Symptomactive2023-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1311Frailty Symptomactive2023-11ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1038Osteoporosis Without Current Fractureactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1050Osteoporosis With Current Fractureactive2018-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1051DXA (Dual energy Xray Absorptiometry) Scanactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1074Frailty Diagnosisactive2019-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1075Frailty Symptomactive2019-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1021Narcolepsyactive2018-08ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1023Narcolepsyactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1024Neurologic impairmentactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1025Neurologic impairmentactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.11.1026Neurologic impairmentactive2021-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.12.1011Narcolepsyactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.114.12.1012Neurologic impairmentactive2024-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1149Substance Use Disorder Long Acting Medicationactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.115.11.1248Retinal or Dilated Eye Examactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.115.12.1088Retinal or Dilated Eye Examactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1150Substance Use Disorder Short Acting Medicationactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1151Substance Use Disorder Long Acting Medication Administrationactive2025-01ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1152Substance Use Disorder Short Acting Medication Administrationactive2024-02ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1155Substance Use Disorder Short Acting Medication Administrationactive2023-11ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1156Substance Use Disorder Long Acting Medication Administrationactive2021-11ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1157Substance Use Disorder Short Acting Medication Administrationactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1163Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccineactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1164Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccineactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1165Hospice Diagnosisactive2022-08ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1166Hospice Diagnosisactive2022-08ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1167Palliative Care Diagnosisactive2022-08ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1168Palliative Care Diagnosisactive2022-08ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1169Palliative Care Diagnosisactive2022-08ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1031Hyperthyroidismactive2018-03ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1033Hyperthyroidismactive2018-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1034Hyperparathyroidismactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1036Hyperparathyroidismactive2018-03ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1015Hyperthyroidismactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1016Hyperparathyroidismactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1170Atomoxetineactive2022-09ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1171Clonidineactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1172Dexmethylphenidateactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1173Dextroamphetamineactive2022-09ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1174Lisdexamfetamineactive2022-09ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1176Methylphenidateactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1177Lower Body Fractures Excluding Ankle and Footactive2022-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1178Lower Body Fractures Excluding Ankle and Footactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1179Malignant Neoplasms of Lower and Unspecified Limbsactive2022-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1042Counseling for Physical Activityactive2019-03ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1077Falls Screeningactive2018-03ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1097CT Colonographyactive2019-03ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.11.1220Frailty Device SNOMEDactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.12.1028Falls Screeningactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.12.1035Counseling for Physical Activityactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.118.12.1300Frailty Deviceactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1180Malignant Neoplasms of Lower and Unspecified Limbsactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1181Mechanical Complications Excluding Upper Bodyactive2022-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1182Mechanical Complications Excluding Upper Bodyactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1183Partial Arthroplasty of Hipactive2022-09ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1184Partial Arthroplasty of Hipactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1188Removal, Revision and Supplement Procedures of the Lower Body and Spineactive2022-12ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1189Removal, Revision and Supplement Procedures of the Lower Body and Spineactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1190Antibiotic Medications for Upper Respiratory Infectionactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1193Malignant Neoplasmsactive2022-09ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1194Malignant Neoplasmsactive2022-09ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1196Atherosclerosis of the Extremitiesactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1197Atherosclerosis of the Extremitiesactive2023-07ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1198Atherosclerosis of the Extremitiesactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1199Lower Extremity Neurological Assessment Result or Findingactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.11.1001Disorders of the Immune Systemactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.11.1003Disorders of the Immune Systemactive2024-02ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.11.1004HIV Viral Loadactive2025-02ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.11.1008HIV 2active2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.11.1010HIV 2active2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.11.1011Severe Combined Immunodeficiencyactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.11.1012Severe Combined Immunodeficiencyactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.12.1001Disorders of the Immune Systemactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.12.1002HIV Viral Loadactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.12.1003HIVactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.120.12.1007Severe Combined Immunodeficiencyactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1200Lower Extremity Neurological Testsactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1201Lower Extremity Visual Inspection Result or Findingactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1202Lower Extremity Visual Inspection Testactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1203Monofilament Test Result or Findingactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1204Monofilament Testsactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1205Pedal Pulse Result or Findingactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1206Peripheral Neuropathyactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1207Peripheral Neuropathyactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1208Peripheral Neuropathyactive2023-07ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1209Amputation of Bilateral Feetactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.11.1011Consultant Reportactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.11.1028BMI percentileactive2017-05ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.11.1030Heightactive2019-03ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.11.1031Weightactive2017-05ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.12.1006Consultant Reportactive2024-09ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.12.1012BMI percentileactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.12.1014Heightactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.121.12.1015Weightactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1210Amputation of Bilateral Feetactive2023-07ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1211Amputation of Bilateral Feetactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1212Amputation of Left Footactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1213Amputation of Left Footactive2023-07ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1214Amputation of Left Footactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1215Amputation of Right Footactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1216Amputation of Right Footactive2023-07ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1217Amputation of Right Footactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1218Amputation of Unspecified Footactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1219Amputation of Unspecified Footactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.122.11.1003Ambulatoryactive2021-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.122.12.1003Ambulatoryactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1220Foot Assessment With Abnormal Result or Findingactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1221Foot Assessment With Abnormal Result or Findingactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1222Acquired Absence of Bilateral feetactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1223Acquired Absence of Bilateral feetactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1224Acquired Absence of Left Footactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1225Acquired Absence of Left Footactive2023-07ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1226Acquired Absence of Left Footactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1227Acquired Absence of Right Footactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1228Acquired Absence of Right Footactive2023-07ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1229Acquired Absence of Right Footactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1230Lower Body Fractures Excluding Ankle and Footactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1231Malignant Neoplasms of Lower and Unspecified Limbsactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1232Mechanical Complications Excluding Upper Bodyactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1233Partial Arthroplasty of Hipactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1234Partial Arthroplasty of Hipactive2023-07ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1235Removal, Revision and Supplement Procedures of the Lower Body and Spineactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1236Removal, Revision and Supplement Procedures of the Lower Body and Spineactive2023-07ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1237Removal, Revision and Supplement Procedures of the Lower Body and Spineactive2023-07ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1238Primary THA Procedureactive2023-07ushl7cms
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1239Foot Ulceractive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1240Foot Ulceractive2023-07ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1241Foot Ulceractive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1242Referral for Foot Careactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1243Therapeutic Footwearactive2023-08ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1244Foot Deformityactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1245Foot Deformityactive2023-07ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1246Foot Deformityactive2023-07ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1247Megestrol Medicationsactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1248Meperidine Medicationsactive2024-01ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1249Potentially Harmful Antidepressants for Older Adultsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.11.1004Fluoride Varnish Application for Childrenactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.11.1007Dental Cariesactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.11.1009Dental Cariesactive2017-05ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.11.1010Clinical Oral Evaluationactive2017-05ushl7
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.11.1011Fluoride Varnish Application for Childrenactive2024-02ushl7
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.12.1002Fluoride Varnish Application for Childrenactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.12.1003Clinical Oral Evaluationactive2017-05ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.125.12.1004Dental Cariesactive2021-02ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1250Potentially Harmful Antihistamines for Older Adultsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1251Potentially Harmful Antiparkinsonian Agents for Older Adultsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1252Potentially Harmful Barbiturates for Older Adultsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1253Potentially Harmful Estrogens for Older Adultsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1254Potentially Harmful Gastrointestinal Antispasmodics for Older Adultsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1255Potentially Harmful Pain Medications for Older Adultsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1256Potentially Harmful Skeletal Muscle Relaxants for Older Adultsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1257Potentially Harmful Sulfonylureas for Older Adultsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1258Substance Use Disorder Long Acting Medicationactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1259Substance Use Disorder Short Acting Medicationactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1260Viloxazineactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1266Diabetic Retinopathy Severity Levelactive2025-01ushl7loinc
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1272Diabetesactive2025-01ushl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.1273Diabetesactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.195.11.1003Counseling for Nutritionactive2017-05ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.464.1003.195.11.1004Counseling for Nutritionactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.195.12.1003Counseling for Nutritionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1001Antibiotic Medications for Pharyngitisactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1078Nifedipine Medicationsactive2022-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1080Contraceptive Medicationsactive2025-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1109Meperidine Medicationsactive2024-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1129Desiccated Thyroid Medicationsactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1143Isotretinoinactive2022-01ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1167Dipyridamole Medicationsactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1205Leucovorinactive2023-07ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1211Aspirin and Other Antiplateletsactive2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1212DTaP Vaccineactive2024-11ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1214Hepatitis A Vaccineactive2018-03ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1216Hepatitis B Vaccineactive2025-04ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1220Child Influenza Vaccineactive2022-02ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1222Inactivated Polio Vaccine (IPV)active2021-09ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1228Pneumococcal Conjugate Vaccineactive2023-11ushl7cvx
us.nlm.vsacR42.16.840.1.113883.3.464.1003.196.11.1232Rotavirus Vaccine (3 dose schedule)active2018-03ushl7cvx